Covidien Acquires Scandius Biomedical Inc.

    Surgical Devices Global Business Unit Expands Sports Surgery Platform

    NORTH HAVEN, CONN., November 8 /CNW/ - Covidien Ltd. (NYSE:   COV, BSX:
COV), a leading global provider of healthcare products, announced today that
one of its subsidiaries has acquired Scandius Biomedical Inc., a developer of
devices for sports-related surgeries. Financial terms were not disclosed.

    Located in Littleton, MA, Scandius Biomedical uses a network of
distributors to sell proprietary products for arthroscopic reconstruction of
the Anterior Cruciate Ligament (ACL): the Stratis(R) ST Femoral Fixation
System and the TriTis(R) Tibial Fixation System. The systems consist of
instrumentation and both non-absorbable and bioabsorbable polymer implants.

    Covidien's Medical Devices segment currently sells a range of products
for sports-related surgeries, including soft tissue repair devices and access

    "The acquisition of Scandius Biomedical demonstrates our commitment to
the growing sports surgery market and enables us to further capitalize on our
historic strengths in minimally invasive surgery," said Scott Flora,
President, Surgical Devices, Covidien. "With the combination of Scandius
Biomedical products and those we have developed internally, Covidien will be
able to offer our customers innovative soft tissue repair devices for common
sports surgery procedures."

    About Covidien

    Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers value
through clinical leadership and excellence. Covidien manufactures, distributes
and services a diverse range of industry-leading product lines, including
Surgical Devices, Energy-based Devices, Respiratory and Monitoring Solutions,
Patient Care and Safety Products, Imaging Solutions, Pharmaceutical Products,
Medical Supplies and Retail Products. With 2006 revenue of nearly $10 billion,
Covidien has more than 43,000 employees worldwide in 57 countries, and its
products are sold in over 130 countries. Please visit to
learn more about our business.

For further information:

For further information: Covidien Ltd. Eric Kraus, 508-261-8305 Senior
Vice President Corporate Communications or Coleman
Lannum, CFA, 508-452-4343 Vice President Investor Relations or Bruce Farmer, 508-452-4372 Director Financial
Communications or Wayde McMillan, 508-452-4387
Director Investor Relations

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890